SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF PHARMACOLOGICAL TREATMENTS AND SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

被引:0
|
作者
Spoorendonk, J. A. [1 ]
Sahbaz Gulser, S. [1 ]
Arca, E. [1 ]
Hurst, M. [2 ]
Zema, C. [3 ]
Contente, M. [2 ]
Krause, T. [2 ]
机构
[1] OPEN Hlth, Rotterdam, Netherlands
[2] Bristol Myers Squibb, Uxbridge, Middx, England
[3] Bristol Myers Squibb, Lawrenceville, NJ USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
MSR97
引用
收藏
页码:S368 / S368
页数:1
相关论文
共 50 条
  • [21] Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy-Reply
    Kim, Luke K.
    Feldman, Dmitriy N.
    JAMA CARDIOLOGY, 2017, 2 (01) : 111 - 111
  • [22] Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy
    Lawin, Dennis
    Lawrenz, Thorsten
    Radke, Kristin
    Stellbrink, Christoph
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (02) : 207 - 217
  • [23] Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy
    Dennis Lawin
    Thorsten Lawrenz
    Kristin Radke
    Christoph Stellbrink
    Clinical Research in Cardiology, 2022, 111 : 207 - 217
  • [24] The efficacy and safety of coil embolization of septal branch in the treatment of patients with obstructive hypertrophic cardiomyopathy
    刘会
    China Medical Abstracts(Internal Medicine), 2018, 35 (01) : 24 - 25
  • [25] Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review
    Bishev, Daniel
    Fabara, Stephanie
    Loseke, Isaac
    Alok, Akankcha
    Al-Ani, Hashim
    Bazikian, Yvette
    HEART LUNG AND CIRCULATION, 2023, 32 (09): : 1049 - 1056
  • [26] Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
    Veselka, Josef
    SWISS MEDICAL WEEKLY, 2007, 137 (47-48) : 657 - 659
  • [27] Percutaneous Radiofrequency Septal Reduction for Hypertrophic Obstructive Cardiomyopathy in Children
    Sreeram, Narayanswami
    Emmel, Mathias
    de Giovanni, Joseph V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (24) : 2501 - 2510
  • [28] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [29] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [30] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Response
    Sigwart, U
    CIRCULATION, 1998, 97 (07) : 709 - 709